MAO-B inhibitor, KDS2010, alleviates spinal nerve ligation-induced neuropathic pain in rats through competitively blocking the BDNF/TrkB/NR2B signaling.

[1]  So Yeong Lee,et al.  Antiallodynic effects of KDS2010, a novel MAO-B inhibitor, via ROS-GABA inhibitory transmission in a paclitaxel-induced tactile hypersensitivity model , 2022, Molecular brain.

[2]  M. Guo,et al.  BDNF Participates in Chronic Constriction Injury-Induced Neuropathic Pain via Transcriptionally Activating P2X7 in Primary Sensory Neurons , 2021, Molecular Neurobiology.

[3]  So Yeong Lee,et al.  High Salt Intake Recruits Tonic Activation of NR2D Subunit-Containing Extrasynaptic NMDARs in Vasopressin Neurons , 2020, The Journal of Neuroscience.

[4]  D. Pinho,et al.  Neuroinflammation, oxidative stress and their interplay in neuropathic pain: focus on specialized pro-resolving mediators and NADPH oxidase inhibitors as potential therapeutic strategies. , 2020, Pharmacological research.

[5]  Shoaib Manzoor,et al.  A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review. , 2020, European journal of medicinal chemistry.

[6]  Ki Duk Park,et al.  Four-week repeated dose oral toxicity study of KDS2010, a novel selective monoamine oxidase B inhibitor, in Sprague Dawley rats. , 2020, Regulatory toxicology and pharmacology : RTP.

[7]  Hyung-Seok Kim,et al.  Excessive Astrocytic GABA Causes Cortical Hypometabolism and Impedes Functional Recovery after Subcortical Stroke. , 2020, Cell reports.

[8]  I. Orhan,et al.  The main targets involved in neuroprotection for the treatment of Alzheimer's Disease and Parkinson Disease. , 2020, Current pharmaceutical design.

[9]  M. Uddin,et al.  KDS2010: A Potent Highly Selective and Reversible MAO-B Inhibitor to Abate Alzheimer's Disease. , 2020, Combinatorial chemistry & high throughput screening.

[10]  Fei Yang,et al.  BDNF promotes activation of astrocytes and microglia contributing to neuroinflammation and mechanical allodynia in cyclophosphamide-induced cystitis , 2020, Journal of Neuroinflammation.

[11]  Dan Wang,et al.  Curcumin alleviates oxaliplatin-induced peripheral neuropathic pain through inhibiting oxidative stress-mediated activation of NF-κB and mitigating inflammation. , 2019, Biological & pharmaceutical bulletin.

[12]  M. I. Coşacak,et al.  Neuron-glia interaction through Serotonin-BDNF-NGFR axis enables regenerative neurogenesis in Alzheimer’s model of adult zebrafish brain , 2019, bioRxiv.

[13]  M. Olianas,et al.  Downregulation of TrkB Expression and Signaling by Valproic Acid and Other Histone Deacetylase Inhibitors , 2019, The Journal of Pharmacology and Experimental Therapeutics.

[14]  T. Müller,et al.  Pharmacokinetics of monoamine oxidase B inhibitors in Parkinson’s disease: current status , 2019, Expert opinion on drug metabolism & toxicology.

[15]  R. Christy,et al.  Involvement of brain-derived neurotrophic factor (BDNF) in chronic intermittent stress-induced enhanced mechanical allodynia in a rat model of burn pain , 2019, BMC Neuroscience.

[16]  Chilman Bae,et al.  Peripheral and central oxidative stress in chemotherapy-induced neuropathic pain , 2019, Molecular Pain.

[17]  Ashwini M. Londhe,et al.  Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s disease , 2019, Science Advances.

[18]  G. Deng,et al.  The activation of BDNF reduced inflammation in a spinal cord injury model by TrkB/p38 MAPK signaling , 2018, Experimental and therapeutic medicine.

[19]  Moeno Kume,et al.  Temporal and sex differences in the role of BDNF/TrkB signaling in hyperalgesic priming in mice and rats , 2018, Neurobiology of pain.

[20]  Zhi-jun Zhang,et al.  Chemokine receptor CCR2 contributes to neuropathic pain and the associated depression via increasing NR2B-mediated currents in both D1 and D2 dopamine receptor-containing medium spiny neurons in the nucleus accumbens shell , 2018, Neuropsychopharmacology.

[21]  Mengyuan Zhang,et al.  BDNF Activates mTOR to Upregulate NR2B Expression in the Rostral Anterior Cingulate Cortex Required for Inflammatory Pain-Related Aversion in Rats , 2018, Neurochemical Research.

[22]  T. Herraiz,et al.  Analysis of monoamine oxidase (MAO) enzymatic activity by high-performance liquid chromatography-diode array detection combined with an assay of oxidation with a peroxidase and its application to MAO inhibitors from foods and plants. , 2018, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[23]  L. Villanueva,et al.  Role of the spinal TrkB‐NMDA receptor link in the BDNF‐induced long‐lasting mechanical hyperalgesia in the rat: A behavioural study , 2017, European journal of pain.

[24]  J. McGinty,et al.  Role of Src Family Kinases in BDNF-Mediated Suppression of Cocaine-Seeking and Prevention of Cocaine-Induced ERK, GluN2A, and GluN2B Dephosphorylation in the Prelimbic Cortex , 2017, Neuropsychopharmacology.

[25]  M. Roghani,et al.  Diosgenin ameliorates development of neuropathic pain in diabetic rats: Involvement of oxidative stress and inflammation. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[26]  D. Stein,et al.  Modification of the association between early adversity and obsessive-compulsive disorder by polymorphisms in the MAOA, MAOB and COMT genes , 2016, Psychiatry Research.

[27]  J. Huie,et al.  Spinal Plasticity and Behavior: BDNF-Induced Neuromodulation in Uninjured and Injured Spinal Cord , 2016, Neural plasticity.

[28]  P. Riederer,et al.  Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression , 2016, Journal of Neural Transmission.

[29]  P. Dunkel,et al.  Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson’s disease , 2016, Molecular Neurodegeneration.

[30]  L. Qiao,et al.  Endogenous BDNF augments NMDA receptor phosphorylation in the spinal cord via PLCγ, PKC, and PI3K/Akt pathways during colitis , 2015, Journal of Neuroinflammation.

[31]  R. Meeusen,et al.  Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target? , 2015, Expert opinion on therapeutic targets.

[32]  Peter A. Smith.  BDNF: No gain without pain? , 2014, Neuroscience.

[33]  N. Asai,et al.  Girdin Phosphorylation Is Crucial for Synaptic Plasticity and Memory: A Potential Role in the Interaction of BDNF/TrkB/Akt Signaling with NMDA Receptor , 2014, The Journal of Neuroscience.

[34]  A. Rancillac,et al.  BDNF-Dependent Plasticity Induced by Peripheral Inflammation in the Primary Sensory and the Cingulate Cortex Triggers Cold Allodynia and Reveals a Major Role for Endogenous BDNF As a Tuner of the Affective Aspect of Pain , 2014, The Journal of Neuroscience.

[35]  T. Müller.  Pharmacokinetic/pharmacodynamic evaluation of rasagiline mesylate for Parkinson’s disease , 2014, Expert opinion on drug metabolism & toxicology.

[36]  A. Pillai,et al.  TrkB interacts with ErbB4 and regulates NRG1-induced NR2B phosphorylation in cortical neurons before synaptogenesis , 2014, Cell Communication and Signaling.

[37]  Howard S. Smith,et al.  Antioxidant therapy for pain relief in patients with chronic pancreatitis: systematic review and meta-analysis. , 2013, Pain physician.

[38]  M. Naoi,et al.  Revelation in the neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms , 2013, Expert review of neurotherapeutics.

[39]  Pradeep J. Nathan,et al.  BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases , 2013, Nature Reviews Neuroscience.

[40]  S. M. Oliveira,et al.  Involvement of monoamine oxidase B on models of postoperative and neuropathic pain in mice. , 2012, European journal of pharmacology.

[41]  F. Carreño,et al.  Brain‐Derived Neurotrophic Factor‐Tyrosine Kinase B Pathway Mediates NMDA Receptor NR2B Subunit Phosphorylation in the Supraoptic Nuclei Following Progressive Dehydration , 2011, Journal of neuroendocrinology.

[42]  H. Kim,et al.  Reactive oxygen species contribute to neuropathic pain by reducing spinal GABA release , 2011, PAIN®.

[43]  S. McMahon,et al.  Perturbing PSD-95 Interactions With NR2B-subtype Receptors Attenuates Spinal Nociceptive Plasticity and Neuropathic Pain , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[44]  R. Pang,et al.  Brain-derived neurotrophic factor contributes to spinal long-term potentiation and mechanical hypersensitivity by activation of spinal microglia in rat , 2011, Brain, Behavior, and Immunity.

[45]  Seung-Ro Han,et al.  Behavioral evidence for the differential regulation of p-p38 MAPK and p-NF-κB in rats with trigeminal neuropathic pain , 2011, Molecular pain.

[46]  Jisheng Han,et al.  Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation , 2010, Experimental Neurology.

[47]  J. van Staden,et al.  Anti-inflammatory, anticholinesterase, antioxidant and phytochemical properties of medicinal plants used for pain-related ailments in South Africa. , 2010, Journal of ethnopharmacology.

[48]  A. Basbaum,et al.  TrkB Signaling Is Required for Both the Induction and Maintenance of Tissue and Nerve Injury-Induced Persistent Pain , 2009, The Journal of Neuroscience.

[49]  Yun-qing Li,et al.  Temporal Changes of Astrocyte Activation and Glutamate Transporter‐1 Expression in the Spinal Cord After Spinal Nerve Ligation‐Induced Neuropathic Pain , 2008, Anatomical record.

[50]  T. Takasusuki,et al.  NMDA receptor 2B subunit-mediated synaptic transmission in the superficial dorsal horn of peripheral nerve-injured neuropathic mice , 2007, Brain Research.

[51]  M. Narita,et al.  Direct evidence for spinal cord microglia in the development of a neuropathic pain‐like state in mice , 2006, Journal of neurochemistry.

[52]  K. Chung,et al.  Levels of mitochondrial reactive oxygen species increase in rat neuropathic spinal dorsal horn neurons , 2006, Neuroscience Letters.

[53]  Y. Sugawara,et al.  Remarkable effect of selegiline (L-deprenyl), a selective monoamine oxidase type-B inhibitor, in a patient with severe refractory depression: a case report. , 2005, Clinical neuropharmacology.

[54]  J. Andersen,et al.  Perspectives on MAO-B in aging and neurological disease , 2004, Molecular Neurobiology.

[55]  L. Culp,et al.  Expression of trkB in Human Neuroblastoma in Relation to MYCN Expression and Retinoic Acid Treatment , 2003, Laboratory Investigation.

[56]  I. Mizuta,et al.  Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes. , 2000, Biochemical and biophysical research communications.

[57]  J. Ritchie,et al.  Paw withdrawal threshold in the von Frey hair test is influenced by the surface on which the rat stands , 1999, Journal of Neuroscience Methods.

[58]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[59]  Jin Mo Chung,et al.  An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat , 1992, PAIN.

[60]  C. Binda,et al.  Monoamine Oxidases. , 2018, Sub-cellular biochemistry.

[61]  Z. Xu,et al.  Whole-cell patch-clamp recordings on spinal cord slices. , 2012, Methods in molecular biology.

[62]  M. Youdim,et al.  Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's disease. , 1994, Life sciences.